Quick Answer
Curanex Pharmaceuticals Inc reported Operating Income of -$4.24 million for fiscal year 2025.
Curanex Pharmaceuticals Inc Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$4.24M | -1061.2% |
| 2024 | -$365.1K | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$951.3K | -919.7% | -1549.9% |
| June 30, 2025 | -$57.7K | -30.4% | +38.2% |
| September 30, 2024 | -$93.3K | — | -111.1% |
| June 30, 2024 | -$44.2K | — | — |
- Curanex Pharmaceuticals Inc showed a decrease of -1061.2% in Operating Income compared to the prior fiscal year.
- Over the 2024–2025 period, Curanex Pharmaceuticals Inc’s operating income has declined by 1061.2% (from -$365.1 thousand to -$4.24 million).
- The most recent figure is from Curanex Pharmaceuticals Inc’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: